Gary Hewett

Gary Hewett

Non-Executive Director

Gary Hewett has developed and commercialised in the US five novel diagnostic products over the course of his career. The first of these, Cholestech LDX, remains widely used nearly 30 years after development. Gary has been part of executive management in three NASDAQ listed companies and has successfully exited companies through trade-sale. Gary is based in the Bay Area of California and has a BSc in Neurobiology from University of California Berkley.